Copley Acquisition Ends Ignite Proteomics SPAC Merger, Faces November 2 Deadline
COPL is trading near its 52-week low of $9.98 (5.9% above the low).
Summary
Copley Acquisition Corp's planned merger with Ignite Proteomics has been mutually terminated. The SPAC now has until November 2, 2026 to find a new target or liquidate.
Key Events · M&A and Partnerships · COPL
-
Business Combination Terminated
Copley and Ignite Proteomics mutually terminated their June 10, 2026 Business Combination Agreement effective October 9, 2026.
-
November 2 Deadline Looms
Copley has until November 2, 2026 to consummate a new business combination, subject to extension under its organizational documents.
-
Going Concern Risk Intensifies
The termination removes the SPAC's only identified merger target while the company already faces a going-concern warning and critically low operating cash.
-
Mutual Releases and Expenses
Each party bears its own expenses, and mutual releases of claims were executed, with only limited BCA provisions surviving.
Analysis · COPL · Real Estate & Construction
Copley Acquisition Corp and Ignite Proteomics mutually terminated their business combination agreement effective October 9, 2026. The SPAC now has until November 2, 2026 to find a new target or face liquidation. This is a critical setback for a company already under a going-concern warning with critically low operating cash. The termination removes the only identified path to completing a business combination, and the clock is running out.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 36.5% of the 953 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.66%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COPL was trading at $10.57 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $191.6M. The 52-week trading range was $9.98 to $10.69. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.